Pfizer to price Covid drug Paxlovid at $1,390 per course
Paxlovid will transition to the private market in November as demand for Covid vaccines and treatments slumps nationwide.
Higher stocks and rates rising this fast? Why history shows this is usually untenable
A higher-for-longer interest rate environment could mean a ‘stalemate’ for equities after their long upward march this year.
Netflix flips the streaming script again with a return to growth mode
After last year’s Great Netflix Correction, Netflix is back in growth mode, adding nearly 9 million subscribers in the second quarter.
Delta walks back some changes to airport lounge access, loyalty program after customer complaints
Delta’s CEO said the company went “too far” in its changes announced last month.
Stakes raised for Powell speech Thursday with 10-year yield on cusp of 5%. Here’s what he could say
Federal Reserve Chair Jerome Powell is set to deliver what could be a key policy address Thursday.
ChatGPT can now respond with images and search the web
OpenAI has officially launched real-time internet browsing and image generation for ChatGPT — but it has been a significantly bumpy ride.
Analysts are nervous heading into Tesla’s third-quarter earnings report
Several Wall Street analysts reduced their price targets on Tesla ahead of its earnings report due Wednesday.
Biden to seek ‘unprecedented’ Israel aid package; pledges $100 million for humanitarian relief in Gaza and West Bank
Biden announced that his administration will commit $100 million to humanitarian assistance in Gaza and the West Bank.
Tesla CEO Elon Musk sounds pessimistic note about economy on earnings call
During the company’s earnings call, CEO Elon Musk said the company’s focused on making its cars more affordable.
Bad news for commercial real estate: Architects report a big drop in business
Architecture firms reported a sharp drop in business in September, indicating that the commercial real estate market could experience even more pain.
